AU2001294786A1 - Use of il-8 protein modulators in the treatment of viral infections - Google Patents
Use of il-8 protein modulators in the treatment of viral infectionsInfo
- Publication number
- AU2001294786A1 AU2001294786A1 AU2001294786A AU9478601A AU2001294786A1 AU 2001294786 A1 AU2001294786 A1 AU 2001294786A1 AU 2001294786 A AU2001294786 A AU 2001294786A AU 9478601 A AU9478601 A AU 9478601A AU 2001294786 A1 AU2001294786 A1 AU 2001294786A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- viral infections
- protein modulators
- modulators
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23491400P | 2000-09-25 | 2000-09-25 | |
US60234914 | 2000-09-25 | ||
PCT/US2001/030222 WO2002024217A1 (en) | 2000-09-25 | 2001-09-25 | Use of il-8 protein modulators in the treatment of viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001294786A1 true AU2001294786A1 (en) | 2002-04-02 |
Family
ID=22883327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001294786A Abandoned AU2001294786A1 (en) | 2000-09-25 | 2001-09-25 | Use of il-8 protein modulators in the treatment of viral infections |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040022762A1 (en) |
EP (1) | EP1322319A4 (en) |
JP (1) | JP2004509147A (en) |
AR (1) | AR030753A1 (en) |
AU (1) | AU2001294786A1 (en) |
WO (1) | WO2002024217A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030753A1 (en) * | 2000-09-25 | 2003-09-03 | Smithkline Beecham Corp | USE OF MODULATORS-PROTEIN OF IL-8, GROALFA, GROBETA, GROGAMMA, NAP-2, AND ENA-78, TO TREAT VIRIC INFECTIONS |
US7052676B2 (en) * | 2000-09-26 | 2006-05-30 | The Regents Of The University Of Michigan | Methods for inhibition of HIV replication using a small molecule inhibitor |
US7282568B2 (en) | 2002-12-16 | 2007-10-16 | Medarex, Inc. | Human monoclonal antibodies against interleukin 8 (IL-8) |
CL2008001071A1 (en) * | 2007-04-17 | 2009-05-22 | Smithkline Beecham Corp | Method to obtain penta-specific antibody against human il-8 / cxcl8, gro-alpha / cxcl1, gro-beta / cxcl2), gro-gamma / cxcl3 and ena-78 / cxcl5; penta-specific antibody; production process of the same; vector, hybridoma or cella that comprises it; pharmaceutical composition; use to treat copd, other diseases. |
EP2276505B1 (en) | 2008-03-20 | 2013-09-18 | TANO, Krister | Nasal spray or nasal drops for treatment of common cold |
EP3409277A1 (en) * | 2017-05-30 | 2018-12-05 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections |
EP3737696A1 (en) | 2018-01-12 | 2020-11-18 | Bristol-Myers Squibb Company | Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0504257A4 (en) * | 1989-11-29 | 1993-03-03 | Brigham And Women's Hospital | (ala il-8) 77 as a leukocyte adhesion inhibitor |
US5543503A (en) * | 1991-03-29 | 1996-08-06 | Genentech Inc. | Antibodies to human IL-8 type A receptor |
CA2181787A1 (en) * | 1994-03-03 | 1995-09-08 | Claire M. Doerschuk | Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
US5890486A (en) * | 1996-12-20 | 1999-04-06 | The Procter & Gamble Company | Thermal nasal dilator and method of treatment for relief of nasal congestion and other symptoms associated with common cold and allergies |
EP1011657A1 (en) * | 1997-07-11 | 2000-06-28 | The Johns Hopkins University School Of Medicine | Nitric oxide inhibits rhinovirus infection |
AU2149600A (en) * | 1998-11-12 | 2000-05-29 | Musc Foundation For Research Development | Methods and compositions for treating common cold symptoms |
AR030273A1 (en) * | 2000-03-10 | 2003-08-20 | Smithkline Beecham Corp | HYDROXIFENIL UREA COMPOUNDS REPLACED WITH SULFONAMIDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINES TO TREAT A DISEASE MEDIATED BY A CHEMIOQUINE |
AR030753A1 (en) * | 2000-09-25 | 2003-09-03 | Smithkline Beecham Corp | USE OF MODULATORS-PROTEIN OF IL-8, GROALFA, GROBETA, GROGAMMA, NAP-2, AND ENA-78, TO TREAT VIRIC INFECTIONS |
-
2001
- 2001-09-18 AR ARP010104398A patent/AR030753A1/en unknown
- 2001-09-25 US US10/381,066 patent/US20040022762A1/en not_active Abandoned
- 2001-09-25 WO PCT/US2001/030222 patent/WO2002024217A1/en not_active Application Discontinuation
- 2001-09-25 AU AU2001294786A patent/AU2001294786A1/en not_active Abandoned
- 2001-09-25 JP JP2002528287A patent/JP2004509147A/en not_active Withdrawn
- 2001-09-25 EP EP01975462A patent/EP1322319A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20040022762A1 (en) | 2004-02-05 |
EP1322319A1 (en) | 2003-07-02 |
AR030753A1 (en) | 2003-09-03 |
WO2002024217A1 (en) | 2002-03-28 |
JP2004509147A (en) | 2004-03-25 |
EP1322319A4 (en) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2404001A (en) | Human proteins having hydrophobic domains and dnas encoding these proteins | |
AU2002346504A1 (en) | Therapeutic protein and treatments | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
AU2002219960A1 (en) | Molecules of the card-related protein family and uses thereof | |
AU2001286721A1 (en) | Human interleukin-four induced protein | |
AU2281601A (en) | Treatment of viral infections using levovirinTM | |
AU9279601A (en) | Compounds and methods for use thereof in the treatment of cancer or viral infections | |
AU2001294786A1 (en) | Use of il-8 protein modulators in the treatment of viral infections | |
AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
AU5032501A (en) | Use of cationic protein hydrolysates | |
AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
AP2002002432A0 (en) | Treatment of viral infections | |
AU2002310922A1 (en) | Interferons in the treatment of ischemia | |
AU2001231987A1 (en) | Polyanionic polyglycosides in the treatment of autism | |
AU2002241570A1 (en) | Human proteins, polynucleotides encoding them and methods of using the same | |
AU2002252773A1 (en) | Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 | |
AU2002241162A1 (en) | Intimins in the prevention or treatment of infections:ii | |
GB2376628B (en) | Treatment of DNA viral infections in cats | |
AU2002316348A1 (en) | Chimeric capsid proteins and uses thereof | |
AU2002343516A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002320621A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002349719A1 (en) | The use of osteogenic growth peptide in the enhancement of haemopoiesis | |
EP1375663A4 (en) | Novel protein, dna thereof and use of the same | |
AU2001273447A1 (en) | Tetraspan protein and uses thereof | |
AU2001241673A1 (en) | Novel human regulatory protein and polynucleotides encoding the same |